Das Karriere-Portal der TGISC Das Karriere-Portal der TGISC

Common challenges of a heterogeneous cluster.

Welcome to the healthcare portal.

Our "Healthcare" consulting cluster covers the fields
medicine (& technology), health insurance, hospitals, biotechnology, pharmaceuticals, wellness/fitness.

 

How to use stem cells from cord blood as special preventative health care and prevent bursting of the red blood cells (hemolysis) during defrosting in HLA typing per separation. And how to reinterpret wellness, create a new product and create 76% higher customer loyalty. Learn this and more in our healthcare portal.

 

Although this cluster consists of heterogeneous industries which in part demonstrate financial interests through different focuses, they share the challenges they face, which can be identified as social changes in health management. Aside from the market potentials of globalization one must also (in addition to the existing domestic) consider regulations due to the European countries and their joint administrative organization merging, which can put a damper on the desire to innovate. 


 

Higher hospital expenses are also accompanied by a growing monetary amount of consumer health care expenses within the health market, representing the social evolution of individualization with an active and integral health belief. All market participants in healthcare must meanwhile accommodate the advanced attitude of consumers, patients or insured, showing an increasing level of knowledge and who in recent years have stepped up their demands on themselves, their health, and care.

 

All fields continue to be confronted with the rapid increase of chronic and psychological illness, associated with the demographic shift and the increased financial cost of an aging society. This increase in costs and demands in general is confronted by the increased use of IT, which is to reduce the organizational and operating costs while also being used in the treatment apparatuses and mechanisms and can innovate these. So this is not to undermine personalized medicine, but instead alleviate treatment and care with adequate offerings in order to bring about customized solutions, and above all to be able to produce increasingly accurate diagnoses and prognoses. 


 

Since the different market participants in the clusters are showing to be so tightly linked and sometimes one’s cost marks another’s earnings, there already are intensive integrations and dependencies. These are surely not always alliances, cooperations and agreements marked by synergies. Exactly where these can still exist must be reviewed in the industries. In addition, the other skills from THOMSEN GROUP International Strategy Consultants, in short: TGISC®’s 30 years of market experience will be of relevance. For example the technology- and skill-intensive health economy will be particularly oriented toward IT solutions.

 

More about the wellness and fitness sector.

What market analysts already described as market saturation in the mid 2000’s proved to be wrong. The consumers' awareness of their health is growing – not just with respect to nutrition and a more conscious lifestyle, but also in the number of gym memberships. The ratio of Germany’s total population is already at 9%, other countries are showing higher numbers with players in the market only partly winning through intensive pricing policy.

 

Even sectors in the medium- and premium range are showing growing numbers and an increase in the number of gyms, since the consumer’s pattern of requirements is diversified – for example the ratio of older gym patrons is growing 

In order to not succumb an illusion of saturation again the parties must continue to work on the elements of their portfolios and present innovative concepts, since the individual needs of the customers in this respect are prominent, since especially the different age groups require offerings to be adapted to their needs while different service concepts are in demand. In pace with this „must“ of market-strategy positioning is an innovative media presence capable to also associate the product with the target group and make it more attractive.



The concepts spreading to areas of different proveniences remains questionable: until now they’re primarily successful in the urban region. How, for example, does the demand characterize in rural areas? New representatives in the fitness sector are especially showing particularly quick and high growth rates here.



The wellness market also still has some development potential on a product level and the People-P of the THOMSEN GROUP 5PAmplify®, which is seen in the expandability of its customer relationship management, which is not yet being adequately utilized as a value added tool. Yet the industry is complaining of an increasingly dilution of the term wellness. One might expect differently, but here it’s especially potentials for market strategy developments which are able to rouse the interest of solvent user groups with a defined and pointed offering and the focused address.
 


Both segments, wellness and fitness, must explore potential partnerships with other members of the cluster and to also advise cross-branch alliances, in this case for example the tourism market might be a promising partner for synergy effects since it is already closely linked to wellness offerings in the hotel industry and in recent years has been able to present promising numbers, which you can trace in our tourism portal.

More about medicine (& technology).

The increasing importance of health factors and their individual perception opens new, promising spheres of activity for the medical technology sector. Based on this shift in awareness medical technology is finding its way into the consumer goods sector, since you can reward yourself and your health by consuming the respective product offers. As a result, in these areas attributes such as usability and for example lifestyle as well, are gaining importance, the closeness to companies in the textile industry can become a strategic asset. Here the keyword is functional wear which, if necessary, can provide continuous real-time monitoring of information on the condition. Preventative health is not connected to illness. Preventative health must be fun. In this respect the industry still has a lot to learn.

 

Actual leaps in innovation can also be tapped in developing potentials giving synergy, for example to the chemical industry and here the production of technical plastics. Nanotechnology is considered a key technology in both sectors. Also the closeness to microelectronics and biotechnology. Cross-company research cooperations with the simultaneous control of strategic mediums of expertise, for example incorporating a university excellence cluster, are now already and increasingly so in the future, deciding factors to increase the real innovation rate with a chance to optimize the costs of the own R&D. This is also among the key task of the TGISC® portfolio. Leaps in innovation require consistently updated versions of knowledge bases, the necessary continuous intra- and interdisciplinary exchange process in multilateral network structures, which should roundly consist of market stakeholders, can be well secured through strategic management, wherein the expertise of validated findings from futurology provides the basis for the aforesaid work.

 

In addition to securing a long-term global growth strategy, medical technology manufacturers will in the future also be seeing enormous market requirements here, an opportunity in the waiting when using relevant FutureAssets®. The demographic shift and foreseeable shortages in care necessitate the use or modified application of conventional medical technology. We’re getting older and more expensive. Keywords paraphrasing a potential avenue in this connection are progressive computerization, miniaturization and automation. While the acceptance rates for intelligent implants are quite good, another future field in medical technology represents a market segment requiring careful handling – keyword robotics.

 

In this context we’re not talking about surgical robotics assisting in extremely complex surgeries with precision, or DNA robots rending cancer cells harmless. Instead we’re talking about support systems such as nursing robots with direct contact to humans providing services for in-patient and in-home care to offset monitoring- and care deficits. While this vision is becoming an increasingly welcome everyday aid in the Asian region, resentments toward these technologies with names such as Paro and Cody are apparently cast in lead in the European region. The innowait system especially determines unused acceptances and prevents the previously described scenario of a product prematurely entering the market.

 

More about health insurance companies.

Without a doubt the next few years are critical years for health insurance companies. The constantly increasing costs of healthcare, institutional regulatory aims with health funds having deficits in the billions are the sword of Damocles for the industry and are hovering over the area of tension of rivaling government and private health insurance. And in the face of the introduction of a uniform contribution rate the even the competition between government health insurance companies is intensifying. The increasing occurrence of consolidation processing, however, is not a realist basis to meet the demand for more competition, especially also since the argument “size equals efficiency” must be challenged.

 


What will bring a rejection of increasing cost pressure? Introducing rewards systems for regular prevention on a personal level represents adapting the social shift toward increased health orientation, but is by far not synonymous with an integral use of the potentials emerging on this basis, which also need to include flexible options. The immense insurance company deficits are among other things resulting from an inadequately accurate fit with respect to the customers’ flexibilized living conditions. Insurance companies can tap potentials if the high assessment of values of individual health is strategically prioritized, thus not capitalized for earnings in the short-term, but in the medium- or long term.

 


Here too the use of new technologies leaves hope for improvement and analogue to the insurance industry, the prospect for automated self-monitoring and the realization of pay-as-you-live approaches is stirring. Loyal existing customer can’t comprehend being refused the use of new, improved product options new customers get to enjoy. As transparent as patient 2.0 will inevitably need to be, the service portfolios of the insurance companies will need to be just as transparent, if not better. The urgently required reduction of administrative costs might be a consequence of this development. For government as well as private insurance companies the increased use of new IT technologies also delineates the possibility of internal process optimization.

 


Future customer relations should be too precious to e.g. argue about the modality of service provisions by phone. While employee skills are also of vital importance as a representation of the brand, their strengths should be exploited more fruitfully. In conjunction with new market strategy initiatives carried out based on an integral analysis and implementation, the employees must instead become a partner of the insured to ensure better access to their real life needs – LiveResearch® by TGISC® will help you.

 

More about hospitals.

Profitability and quality determine the future of hospitals. The increasing competition with an increasing tendency to privatize and ability to invest varying from hospital to hospital leaves an inconsistent overall picture of the market.

 


While there certainly is potential for further cost optimization, the question of sustainability is decided in redefining quality standards. Perceptions of quality, on the other hand, vary from target group to target group. Here developing a high-profile bracket in form of a consensual greater quality standard is a big challenge. In this management must inexpensively adopt the specifics of their own regional market. Starting with the age distribution of the regional population all the way to identifying specific backgrounds with an expectably high need for medical care and the integration of offerings based on knowledge of their individual standards.

 


While a measure for comprehensive quality assurance may be the forced networking of medical competence on a patient-related level, the social shift with a different attribution of the impact of the value of health represents another Action field.

 


The ambiguous line between lifestyle and health, fundamentally changing sets of requirements in the quality of medical services provided changes the way hospitals will need to be designed in the future to meet needs. The quality of patient-related services is a central action field across target groups in hospital management and puts Human Resources into a spotlight of profound importance. In view of the current reality of a shortage of doctors this probably appears grotesque.

 


But despite the still existing myth of the half-god in white, in this context it’s not only the specialized personnel which must integrally typify the vital services impulses but also the care personnel primarily responsible for assuring quality stays. Quality stays are in direct connection with the yielding further changes of recovery. The hospital of the future must break free from all the old stereotypes in this respect and evolve from a place of illness to a place of life. Even an effectively clear pattern based on the qualities of the stay can gain competitive ground.

 

More about biotechnology.

Since 1984 the German biotech market has been relatively quiet, and although there are a variety of growth sectors actual big leaps in innovation originating from Germany have become rare. The different fields of biotechnology applications keep diversifying along with the growing challenges in these areas. While the institutional climate is mildly friendly, it doesn’t go without restrictions. But the political goal is to promote the industry since there are plenty of market requirements.

 


Developing fuels from biomass to be ready for the market is based on white biotechnology methods and is urgently needed. The challenges in the health industry, with the integration of medical technology applications and methods, a field of “red” biotechnology, are to bring about quantum leaps in treating the diseases of our civilizations. So there certainly is no lack of urgency in this sector.

 


Whether it’s generic circuits or self-organized molecule clusters in nanotechnology, engineering product organisms is long under way. In fact, in system biology where living systems are illustrated and modeled to their entire complexity, the research fields of chemists, mathematicians and engineers are consolidating. For example, it’s microsystems technology that makes it possible to integrate nanotechnology into microenvironments. This opens room for new cooperation models to ensure the necessary fundamental knowledge flows into the innovation processes early on and where the updating and optimization can be facilitated more specifically, if necessary.

 


In this sense the next quantum leap of biotechnology innovations can only be achieved as a joint product of all stakeholders involved in the market or through an innovation-focus system such as that of TGISC®.

More about pharmaceuticals.

The price consciousness of customers is on the rise. Stricter licensing requirements for medications and the sinking efficiency rates in research and development present an enormous challenge for the pharmaceuticals industry. In a blend of global opportunities and locally varying restrictions – if nothing else the market for stem cell banking shows how dissected the market environments are in a global comparison – makes it more difficult for companies to identify the FutureAssets® of their own sustainability.

 


Very few of new active ingredients eventually make it to the pharmacy. The time of great blockbuster medications seems to have passed. In addition, numerous patents will be expiring in the next few years, which will further increase competition pressure on the part of generics manufacturers. Furthermore, the needs vary from market to market. They even vary within the group of EU countries. Medications working in Europe aren’t necessarily equally effective in other regions around the world. The reason being the difference in the genetic characteristics of the respective population. Production subject to high needs for flexibility and demanding a distribution network with responsive market-strategy are key assets of the future ability to compete.

 


For many companies in the industry centralizing while diversifying is the order of the day. But compensating for enacted reductions of costs as an outcome of the healthcare reform by optimizing the own cost structures can’t be the royal road to the future. For example innovative power is inhibited instead of strategically bundling it and utilizing it more intently. The willingness for interdisciplinary research cooperations can bring the necessary push for dynamization in this conflict situation. But their target course will gain success if the key criterion is not feasibility but instead the pattern of requirement far from the without a doubt well known issues. Pattern of requirement in turn is identified with suitable tools such as the innowait system with its validated futurology.

 


The area of virtual research could furthermore be expanded to allow for significant time savings in conducting for example clinical studies.

 

Furthermore, the manufacturing logic in the pharmaceuticals industry should increasingly be based on the new prevention markets. Medications are intended to treat what is now supposed to actually be avoided through prevention. In view of increasing spending in the area of preventive care and services this is exactly where we should look for the FutureAssets® of the pharmaceuticals industry of tomorrow.

 

References

Of course, all clients enjoy maximum confidentiality with us. Many prefer even more protection which extends to stating the client’s name. We are, of course, happy to take account of this request. Therefore, below you will find some selected statements of our clients. References.

Is your employer as fit?


The special program for the employees of the TGISC®.  

More about HealthyFun

Bad atmosphere in the vacuum.

 

Top-price segment vacuum cleaner was like lead on the shelves.

The solution of the TGISC®

Call now: +49 40 66 90 90 80
xing kununu linkedIn facebook youtube Google+ twitter